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Background. Augmentation index (AIx) is traditionally obtained from pressure waveforms via arterial applanation tonometry. We
sought to evaluate the association between AIx obtained from peripheral arterial tonometry (PAT) with cardiovascular risk factors
(CRF) and coronary artery disease (CAD). Methods. 186 patients were enrolled in the study. The presence or absence of CRFs and
CADwasassessedineachsubject.AIxwascalculatedbyanautomatedalgorithmaveragingpulsewaveamplitudedataobtainedvia
PAT. Central blood pressures were assessed in a subset of patients undergoing clinically indicated cardiac catheterization. Results.
An association was observed between AIx and age, heart rate, systolic blood pressure, mean arterial pressure, pulse pressure, body
weight and body mass index. AIx was signiﬁcantly lower in patients with <3 CRFs compared to those with >5C R F s( P = .02).
CAD+ patients had signiﬁcantly higher AIx compared to CAD− patients (P = .008). Area under the ROC curve was 0.604 (P<
.01). In patients undergoing cardiac catheterization, after adjusting for age, height and heart rate, AIx was a signiﬁcant predictor
of aortic systolic and pulse pressures (P<. 05) Conclusion. AIx derived from PAT correlates with cardiac risk factors and CAD. It
may be a useful measure of assessing overall risk for coronary artery disease.
1.Introduction
A portion of the arterial pressure wave travelling towards
the extremities is reﬂected back from peripheral impedance
points. In healthy individuals, the reﬂected wave returns
to the aorta during diastole. With age and in the presence
of vascular disease, arterial compliance decreases, and the
arteries become stiﬀ, thereby reducing the transit time
for the incident and reﬂected waves. Consequently, the
reﬂected wave arrives at the aorta during systole of the
same cardiac cycle augmenting the central blood pressures.
This augmentation of central pressure can be quantiﬁed by
augmentation index (AIx), deﬁned as the percentage of the
central pulse pressure attributed to the reﬂected pulse wave.
AIx has been shown to be associated with cardiovascular
risk [1], predicts the presence or absence of coronary
artery disease (CAD) [2, 3], and has been shown to be
an independent predictor of cardiovascular events and
all-cause mortality in select patient populations [4, 5].
Conventionally, AIx is obtained from pressure waveforms
via applanation tonometry of the carotid or radial arter-
ies. Recently, it has been demonstrated that AIx can be
measured from digital pulse wave volumes by peripheral
arterial tonometry (PAT) [6, 7], and that it is associated
with ventricular-vascular coupling [8]. The value obtained
by AIx derived by PAT correlates with that obtained by
conventional radial applanation tonometry; however, they
cannot be used interchangeably since the actual values do
not match since they are obtained from two distinct vascular
beds via two diﬀerent methods. Little is known about the
pathophysiological correlates of PAT-derived AIx. Therefore,
we sought to evaluate the association between PAT-derived
AIx and cardiovascular risk factors (CRFs) and/or CAD.
2. Methods
2.1. Patient Population
Study 1. 146 patients recruited from the Cardiology Clinic
at Tufts Medical Center in Boston were enrolled in the study.2 Cardiology Research and Practice
Table 1: Study population characteristics.
Total population (n = 186) Number of cardiac risk factors P value
<3( n = 64) 3–5 (n = 77) >5( n = 44)
Age, yrs 59 ± 15 4 ± 1∗† 60 ± 16 1 ± 1 .0001
Females, n (%) 57 (36) 18 (51)∗† 28 (41) 11 (13) .01
Menopause, n (%) 35 (61) 12 (67)∗ 14 (50) 9 (81)‡∗ .01
Heart rate, beats per minute 68 ± 17 0 ± 1∗† 66 ± 16 4 ± 2. 0 4
Mean arterial pressure, mmHg 103 ± 19 9 ± 2∗† 103 ± 1 106 ± 1 .009
Systolic blood pressure, mmHg 128 ± 1 124 ± 2 129 ± 2 127 ± 2. 1 8
Diastolic blood pressure, mmHg 76 ± 17 8 ± 17 6 ± 17 1 ± 1∗‡ .006
Pulse pressure, mmHg 51 ± 14 5 ± 1∗† 52 ± 15 6 ± 2 .008
Height, inches 67.8 ± 0.5 65 ± 1∗† 68 ± 0.5 70 ± 0.3 .01
Weight, pounds 192.9 ± 2.8 183 ± 6† 191 ± 3† 209 ± 4. 0 2
Body mass index, kg/m2 29.7 ± 0.4 29.5 ± 1 29.4 ± 1.8 30.7 ± 0.6∗‡ .06
Total cholesterol, mg/dL 174 ± 3 194 ± 5∗† 168 ± 4 155 ± 6.3 .03
HDL cholesterol, mg/dL 42 ± 95 0 ± 2∗† 39 ± 23 6 ± 9. 0 3
LDL cholesterol, mg/dL 103 ± 3 116 ± 7∗† 99 ± 59 2 ± 5. 0 4
Triglycerides, mg/dL 158 ± 10 131 ± 11 170 ± 19 152 ± 15 .290
Hypertension, n (%) 96 (52) 6 (17) 31 (46)†‡ 59 (71)∗‡ .03
Diabetes mellitus,n (%) 44 (24) 0 (0) 9 (14)‡† 35 (42)∗‡ .0001
Hypercholesterolemia,n (%) 109 (58) 2 (6) 37 (54)‡† 70 (84)∗‡ .0001
Smoke, n (%) 82 (44) 7 (20) 27 (40) 48 (58) .201
Family history, n (%) 65 (35) 5 (14) 23 (34)‡† 37 (45)‡ .001
Coronary artery disease, n (%) 102 (55) 7 (11) 53 (68)‡† 42 (95)‡ .001
Augmentation index, (%) −4.86 ± 1.4 −5.15 ± 2.09† −3.60 ± 1.69 5.65 ± 2.55 .02
‡Signiﬁcantly diﬀerent from cohort with <3C R F s .
∗Signiﬁcantly diﬀerent from cohort with 3–5 CRFs
†Signiﬁcantly diﬀerent from cohort with >5C R F s .
Subjects were instructed to fast overnight and to refrain from
smoking,caﬀeine,oralcoholonthedayoftesting.Vasoactive
medicines were withheld for a period of 12 hours prior to
testing.
Study 2. 40 consecutive patients undergoing clinically
indicated nonemergent left heart catheterization were
retrospectively identiﬁed for inclusion into this study. As
partofthestandardcatheterizationprotocol,bloodpressures
were measured within the femoral artery, ascending aorta,
and the left ventricle using a 6-French end hole ﬂuid-ﬁlled
catheter and a pressure manometer prior to injection of any
contrast agent. Pressures within the ascending aorta were
considered as the central blood pressure (CBP) in the study.
The presence or absence of the following cardiovas-
cular risk factors was assessed in all the subjects from
both substudies: male gender, hypertension (systolic blood
pressure >140mmHg, diastolic blood pressure >90mmHg,
or being on an antihypertensive medication), hyperlipi-
demia (serum cholesterol >220mg/dL or taking lipid-
lowering medication), diabetes mellitus (fasting blood glu-
cose >140mg/dL or on oral hypoglycemics or insulin),
family history of CAD (ﬁrst-or second-degree relatives with
premature CAD), postmenopausal women, and smoking
(havingsmokedatleastﬁvetimesperdaywithinlastmonth).
CAD was deﬁned as the presence of ischemia or infarction
onsingle-photonemission-computedtomographic(SPECT)
nuclearmyocardialperfusionimagingor>50%stenosisofan
epicardial coronary artery by angiography.
Patients with moderate to severe heart failure (NYHA
class III-IV, LVEF < 35), hemodynamic instability, peripheral
arterial disease (Ankle-brachial Index <0.9), and ﬁnger
deformities were excluded from the study. This study was
approved by the Institutional Review Board at Tufts Medical
Center. A written informed consent was obtained from all
subjects.
2.2. Augmentation Index Measured by Peripheral Arterial
Tonometry (PAT-AIx). Prior to collecting vascular measures,
all study subjects rested in a quiet dark room for a
period of 10 minutes. Post-acclimatization, the vascular data
was recorded by PAT (EndoPAT2000, Itamar Medical Ltd,
Caesarea, Israel) for a period of 5 minutes with the patient
in supine position. The procedure for obtaining AIx is
essentially the same as described in previous reports [9].
The probes, lined by inﬂatable balloons, are connected to
isolated volume reservoirs within the machine, which buﬀer
pressure changes and provide a uniform pressure ﬁeld. Also,
the counter-pressure imparted by the balloon prevents distal
venous distension and blood pooling, which might induce
a local venoarteriolar vasoconstriction reﬂex [10, 11]. The
PAT system is designed to unload arterial wall tension and
increase the range of arterial wall motion without inducingCardiology Research and Practice 3
potentially confounding vasomotor changes. Pressure sen-
sors within this cap capture beat-by-beat ﬁnger pulse wave
amplitude (PWA) which is then ﬁltered, ampliﬁed, and
graphically displayed on a computer screen. A computerized
algorithm has been generated to automatically identify peak
pressures and inﬂection point as previously described by
Kelly et al. [12] and Takazawa [13]. PAT-AIx is calculated by
averaging the PWA data over an epoch of 3.5 minutes and is
calculated by the following formula: PAT-AIx = (P2 − P1) ×
100 /P 1(%), where P1 = pulse pressure and P2 = pressure
corresponding to the inﬂection point.
2.3. Statistical Analysis. Data were entered into MS-Excel
and analyzed with SPSS (SPSS Inc., Chicago, Ill, USA).
Data are expressed as mean ± SEM. A priori signiﬁcance
was set at P<. 05. Normality of distributions was
assessed using Kolmogorov-Smirnov and Shapiro-Wilk tests.
Continuous variables were analyzed according to the student
t-test and Pearson correlation. Dichotomous variables were
analyzed by means of the χ2 analysis. Cardiac risk factors
(age >45yrs in men and >55yrs in women, male gender,
menopause, hypertension, hypercholesterolemia, cigarette
smoking, diabetes mellitus and family history of CAD) were
tabulated as nominal variables. Depending upon the total
number of CRFs per patient, the study population was
divided into tertiles, including those with <3 CRFs, 3–5
CRFs, and >5 CRFs. Analysis of variance (for parametric
data) with Scheﬀe post hoc testing was performed to
assess diﬀerence in continuous variables between groups.
A stepwise multiple regression analysis was performed to
examine predictors of AIx. Binary logistic regression analysis
( 0 . 0 5t oe n t e r ,0 . 1 0t or e m o v e )w a su s e dt oe v a l u a t e
for relationship between AIx and CAD and to evaluate
for potential confounders including age, gender, height,
heart rate, presence of hypertension, hypercholesterolemia,
diabetes mellitus, tobacco use, and family history of CAD. A
receiver operator characteristic (ROC) curve was generated
to determine the predictive power of AIx for CAD.
3. Results
3.1. Subject Population. 186 subjects (129 men, 57 women)
with an average age of 59 ± 1 years were enrolled. 61%
of women were postmenopausal, and 35% were on hor-
mone replacement therapy. 55% patients had CAD, 52%
patients had hypertension, 24% were diabetic, 58% had
hypercholesterolemia, 44% were smokers, and 35% had
family history of CAD. Detailed characteristics of the study
population are described in Table 1.
3.2. Relationship between Peripheral AIx and Cardiac Risk
Factors. AsigniﬁcantassociationwasobservedbetweenPAT-
AIx and age (r = 0.265, P<. 0001), heart rate (r =− 0.299,
P<. 0001), diastolic blood pressure (r =− 0.285, P<
.0001), mean arterial pressure (r = 0.170, P<. 045), and
pulse pressure (r = 0.198, P = .012). The relationship
between PAT-AIx and age best ﬁtted a quadratic regression
model (P = .01). AIx was not associated with diabetes
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Figure 1: Patients with >5 cardiac risk factors had a signiﬁcantly
higher PAT-AIx compared to those with <3C R F s( P = .02). PAT-
AIx in patients with 3–5 cardiac risk factors was not signiﬁcantly
diﬀerent from those with <3o r>5 CRFs.
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Figure 2: CAD− patients have signiﬁcantly lower PAT-AIx values
than CAD+ patients (P = .008).
mellitus, smoking status, or family history of CAD. Similarly,
no signiﬁcant correlation was observed between PAT-AIx
and systolic blood pressure, gender, height, and lipids.
Stepwise multiple regression analysis identiﬁed age, heart
rate, diastolic blood pressure, weight, and cigarette smoking
as predictors of PAT-AIx. Analysis of variance (Scheﬀep o s t
hoc testing) revealed a signiﬁcant diﬀerence in AIx between
patients with <3C R F s( −5.15 ± 2.09%) and those having >5
CRFs (5.65 ± 2.55%, P = .02, Figure 1). PAT-AIx in patients
with 3–5 cardiac risk factors was not signiﬁcantly diﬀerent
than in those with either <3o r>5C R F s .
3.3. Relationship between Peripheral AIx and CAD. PAT-
AIx was signiﬁcantly higher amongst CAD+ patients (1.01
± 1.6%) as compared to CAD− patients (−5.46 ± 1.7%,
P = .008, Figure 2). To examine the ability of PAT-AIx
to predict CAD+, the area under the ROC curve yielded a
value of 0.604 (P<. 01, Figure 3). After dividing the study
population into tertiles based on the PAT-AIx values, there
wasastepwiseincreaseinprevalenceofCADwithanincrease
in PAT-AIx (P<. 05, Figure 4). However, after adjusting4 Cardiology Research and Practice
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Figure 3:TheclassiﬁcationperformanceofperipheralAIx,assessed
by generating a receiver operated characteristic curve, revealed an
AUC of 0.604 (P<. 01).
0
10
20
30
40
50
60
70
Tertile-I Tertile-II Tertile-III
Prevalence of CAD across tertiles of AIx
(%)
P
r
e
v
a
l
e
n
c
e
o
f
C
A
D
64.3%
53.3%
43.6%
Figure 4: Prevalence of CAD in study patients divided into tertiles
based on their PAT-AIx results. The highest number of CAD cases
wasfoundinthetertilewiththehighestPAT-AIxvalues(TertileIII).
Tertile I, having the lowest PAT-AIx values, had the lowest number
of CAD cases.
for potential confounders, including age, sex, heart rate,
smoking, diabetes, hypertension, and hypercholesterolemia,
PAT-AIx was not signiﬁcantly diﬀerent between these two
groups.
3.4. Relationship between Digital AIx and Central Blood
Pressures. A positive correlation was noted between periph-
erally derived AIx and centrally measured blood pressures.
PAT-AIx correlated with aortic systolic pressure (r = 0.480,
P = .002, Figure 5), and aortic pulse pressures (r = 0.455,
P = .004, Figure 6). After adjusting for age, height, and heart
rate, AIx remained a signiﬁcant predictor of aortic systolic
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Figure 5: Positive correlation between PAT-AIx and aortic systolic
blood pressure (r = 0.480, P = .002).
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Figure 6: Positive correlation between PAT-AIx and aortic pulse
pressure (r = 0.455, P = .004).
pressure (β = 0.449, 95% CI 0.187–0.712, P = .001) and
aortic pulse pressure (β = 0.424, 95% CI 0.042–0.805, P =
.0031).
3.5. Relationship between Peripheral AIx and Medications.
Analysis focusing on eﬀects of medications on peripheral
augmentation index revealed a signiﬁcant association
between PAT-AIx with beta-blockers (P = .018) and ACE
inhibitors (P = .03). There was no association between
PAT-AIx and calcium blockers, angiotensinogen receptor
blockers, nitrates, statins, digoxin, diuretics, oral hypo-
glycemics, insulin, thyroid hormone supplements, antide-
pressants, and steroids.
4. Discussion
Our study was undertaken to evaluate the association of
peripheral AIx and cardiovascular risk factors. Similar to
what has been found with AIx derived from applanation
tonometry [1], PAT-derived AIx correlates with age, weight,
BMI, heart rate, diastolic blood pressure, pulse pressure,Cardiology Research and Practice 5
and mean arterial pressure. PAT-AIx was also signiﬁcantly
related to age. Previous studies have noted that the increase
in AIx with age is not linear [1]. In alignment with previ-
ously published data, a quadratic model best illustrates the
relationship between age and PAT-AIx. AIx values increased
with age up to 65–70 years of age. Beyond that, the AIx
values tended to plateau and then decrease shortly after that.
It has been observed that AIx measured by conventional
applanation tonometry begins to plateau at the age of 60
years. This observed diﬀerence can be explained in part by
impedance matching. Impedance matching may diﬀer in the
handcirculationversustheaortaastheremaynotbechanges
in digital endothelial function with aging [14].
PAT-AIx was associated with the cumulative CRFs bur-
den in this study population. Patients with >5C R F sh a da
signiﬁcantly higher PAT-AIx as compared with those having
only a few CRFs. Similarly, when the prevalence of CAD was
assessed across tertiles of PAT-AIx, it was noted that patients
in the highest tertile had a signiﬁcantly higher prevalence of
CAD as compared to those in the lower tertiles.
PAT-AIx was able to discern the presence or absence
of CAD amongst a heterogeneous patient population with
varying in cardiovascular risk. The classiﬁcation perfor-
mance of peripheral AIx was assessed by generating a
receiver-operated characteristic curve which revealed an
AUC of 0.604. However, after adjusting for traditional risk
factors such as age, sex, heart rate, height, weight, hyperten-
sion, diabetes mellitus, hypercholesterolemia, smoking, and
family history of premature coronary heart disease, AIx lost
its statistical signiﬁcance. Thus, PAT-derived AIx is not an
independent predictor of CAD in this population.
The importance of assessing central blood pressure lies
in the fact that traditionally measured brachial artery blood
pressure is often a poor representation of actual central
pressures. Due to pressure wave ampliﬁcation, the brachial
systolic pressure can be up to 20mmHg higher than the
aortic systolic pressure [15–17]. Since the left ventricle
works against pressures within the ascending aorta, aortic
pressures play a signiﬁcant role in the pathophysiology of
cardiac disease. As such, aortic systolic and pulse pressures
can be considered as novel cardiovascular risk factors since
they are predictors of cardiovascular events, target organ
damage, and mortality [18]. Compared to brachial systolic
and pulse pressure, aortic pulse pressure appears to be a
better predictor of the presence and extent of coronary
atherosclerosis [19, 20] and restenosis after coronary inter-
vention [21]. Furthermore, a reduction in central blood
pressure results in a reduction in cardiac hypertrophy,
vascular thickness, and adverse cardiac events [22–24]. For
example, a 10mmHg reduction in aortic pulse pressure has
been shown to translate into a 13–15% reduction in CV
events and all-cause mortality [25, 26]. In alignment with
datapublishedbyMuniretal.[27],ourstudyrevealsthatAIx
measured by PAT also closely correlates with central aortic
blood pressures.
We do acknowledge certain limitations in this study.
While it has been suggested that arterial stiﬀness and
augmented pressure from wave reﬂections make the most
signiﬁcant contributions to the digital volume pulse inﬂec-
tion point, vascular correlates or PAT-AIx remain unex-
plored. CAD was deﬁned on the basis of diagnosis with
angiography and/or positive SPECT imaging. It is true
that SPECT imaging results do not always correlate with
severity of coronary artery stenosis. However, we chose
stress testing because it provides physiologic information
regarding ischemia and prior infarction. While SPECT
imaging does not confer 100% sensitivity and speciﬁcity, this
technique is a reliable, noninvasive assessment of myocardial
ischemia/infarction. In Substudy 2, central pressures were
obtained using conventional ﬂuid-ﬁlled catheters, rather
than high-ﬁdelity pressure transducers. In addition, AIx was
not obtained simultaneously during catheterization when
actualcentralpressurevalueswereobtained.Rather,PATwas
performed at the bedside following cardiac catheterization.
5. Conclusion
PAT has been under investigation over recent years as a tech-
nique for assessment of vascular endothelial function. The
present data suggest that this simple, noninvasive technique
may also provide information regarding augmentation
index. Our ﬁndings suggest that ﬁnger-derived AIx may be
comparable to applanation tonometry for measurement of
augmentation index and evaluation of cardiovascular risk.
However, as observed by Haller et al. [6], although the values
of AIx obtained by PAT correlate with that obtained by
conventional radial applanation tonometry, they cannot be
usedinterchangeablysincetheactualnumbersdonotmatch.
Additional research is needed to identify the underlying
vascular physiology modulating PAT-AIx. Further validation
is warranted in large scale studies comparing PAT-AIx with
thatobtainedbythecurrentgoldstandardradialapplanation
tonometry in a wider patient population.
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